ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0315

Cross-sectional analysis of association between erosive hand osteoarthritis and cardiovascular disease.

Avanika Mahajan1, Caroyln Harvey2, Andy Abril3 and Megan Sullivan4, 1Mayo Clinic, Scottsdale, 2Mayo Clinic, Phoenix, AZ, 3Mayo Clinic Florida, Jacksonville, 4Mayo Clinic Arizona, Scottsdale, AZ

Meeting: ACR Convergence 2025

Keywords: Atherosclerosis, Cardiovascular, Erosions, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Erosive hand osteoarthritis (EHOA) is an inflammatory subtype of hand OA that causes subchondral bone erosion and cortical destruction, often resulting in debilitating symptoms. The association between inflammation, dysregulated immunity and cardiovascular event (CVE) risk is well established1. Specifically, several previous studies have found an increased risk of CVE in patients with rheumatoid arthritis (RA)2. Given the common denominator of inflammation in RA and EHOA, we hypothesized that EHOA is associated with increased CVE risk.

Methods: Patients with EHOA were identified from the electronic medical record by ICD code or by utilizing radiograph reports containing the term “erosive osteoarthritis”. Radiographs were reviewed to confirm the characteristic changes of EHOA, namely central erosions and joint space narrowing within the distal and middle interphalangeal joints. Patients with autoimmune arthritis were excluded. Age and gender matched controls were identified in a 1:3 ratio. Study variables included BMI, smoking history, Type II diabetes and statin use. The primary outcome was any cardiovascular disease, while secondary outcomes were myocardial infarction (MI), hypertension (HTN), arterial disease, atherosclerosis, ischemic heart disease or cerebral infarction that were identified using ICD-9 and ICD-10 codes. EHOA and control groups were univariately compared using equal variance two-sample t-tests for continuous variables and Chi-square tests for categorical variables. Differences between cases and controls was estimated using logistic regression modeling adjusted for BMI and smoking history.

Results: We observed a positive association between EHOA and history of 1) any CVE, 2) arterial disease, 3) atherosclerosis, and 4) HTN. The adjusted odds ratio (OR) calculated using multivariate regression analysis was 1.65 (95% CI: (1.15-2.38); p-value 0.007) for overall prevalence of CVE, 1.71 ((95% CI: 1.24-2.37); p-value 0.001) for arterial disease, 2.51 ((95% CI: 1.70-3.69); p-value< 0.001) for atherosclerosis and 1.68 ((95% CI: 1.21-2.34); p-value 0.002) for HTN . The OR was similar without adjusting for covariates.

Conclusion: Our study shows that patients with EHOA have a higher prevalence of any CVE compared with age and gender matched controls with and without adjustment for potential confounders. Within CVEs, it shows higher prevalence of arterial disease, atherosclerosis and HTN. Our findings are in agreement with prior studies performed with RA patients, thus reinforcing the link between inflammation and increased cardiovascular link. Further studies are warranted to explore this association between EHOA and cardiovascular disease.

Supporting image 1Table 1: Baseline patient characteristics with Descriptive stats and univariate comparison

(case vs control). Case=EOA patient, Control=non-EOA patient.

Supporting image 2Table 2: Univariate and multivariable logistic regression modeling (adjusted for BMI, smoking history, statin use, diabetes). Odds ratios and 95% CIs for the case/control status variable listed. Each outcome is modeled separately. N&#3f848 for each univariate model. N&#3f834 for each multivariable model (14 pts are missing BMI and excluded from multivariable analysis).


Disclosures: A. Mahajan: None; C. Harvey: None; A. Abril: None; M. Sullivan: None.

To cite this abstract in AMA style:

Mahajan A, Harvey C, Abril A, Sullivan M. Cross-sectional analysis of association between erosive hand osteoarthritis and cardiovascular disease. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/cross-sectional-analysis-of-association-between-erosive-hand-osteoarthritis-and-cardiovascular-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cross-sectional-analysis-of-association-between-erosive-hand-osteoarthritis-and-cardiovascular-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology